MRC1 and endometrial cancer: In contrast, MMR germline carriers with ovarian cancer showed higher somatic variant rates in oncogenic driver genes, suggesting a heterogeneous etiology of tumorigenesis mediated by MMR germline variants in endometrial cancer.